Fortaz
Product Images NDC 52565-109

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fortaz (NDC 52565-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teligent Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pbp Label (Fortaz 6g Pbp 109 01)

Pbp Label (Fortaz 6g Pbp 109 01)
This is a pharmacy bulk package for Fortaz (ceftazidime for injection) equivalent to 6 g of anhydrous ceftazidime. It is not for direct infusion and requires further dilution for intravenous use. The package insert should be consulted for dosage and administration. The vial is under reduced pressure and must be handled carefully during the process of constiuton. A series transfer device should be used under a laminar flow hood for prompt use. Once constituted, the solution contains approximately 1g of ceftazidime activity per 5 L and occupies a volume of about 31.5 mL. Any unused portion must be discarded within 4 hours after initial entry. The package contains 709 mg of sodium carbonate, which translates to approximately 54 mg (2.3 ME) of sodium per gram of ceftazidime. It is made in Italy and distributed by Tefgent Pharma, Inc. in Buena, NJ.*
FDA Label Image

Structure (Fortaz Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.